All Type of News
Daewoong picked as best enterprise for better management-labor union relations
Daewoong Pharm received the top prize of this year's employee-friendly enterprise, given by the minister of labor.
This is the first award offered to a pharmaceutical firm in recognition of improving better relati...
Preservative-free artificial tears launched by SamilSamil Pharm has introduced into domestic market its EYE2O, a new-concept artificial tears eye drop.
Artificial tears are lubricant eye drops used to treat the dryness and ir...
|
Merck's new oral antidiabetic agent joins domestic type 2 diabetes market
A new diabetes medication has joined the arsenal of drugs available to treat type 2 diabetes.
The Korea Food and Drug Administration (KFDA) has recently approved sitagliptin phosphate (Januvia), an oral diabetes me...
NHIC seeks to narrow gap in second round of talks
The National Health Insurance Corporation (NHIC) aims to narrow differences and start bargaining in earnest with the Korea Pharmaceutical Association during a second round of negotiation over the NHI payment for the h...
Seoul National University ranks first among 18 universities in reputation
Seoul National University ranked first among 18 pharmacy colleges nationwide in terms of professors' capacity, educational environment and development, the daily Choongang Ilbo said on September 29.
According t...
Boryung will create better futureBoryung Pharmaceutical Group celebrated on October 1 the 50th anniversary of starting its pharmaceutical operations and shared hopes that Boryung will become the leading group i...
|
Ahngook Pharm to hire 60 employees
Ahngook Pharm plans to recruit 60 employees as the hiring has been necessary in consideration of its active advancement in the biotechnology, according to a company spokesman.
Job seekers who are scheduled to gradu...
Concerns mount among Korean drug makers
The domestic pharmaceutical sector is expected to face an inevitable blow following the government's recent decision that Daewon Pharm's new oral medication Peluvi (felubiprofen) is not reimbursable.
The Health Ins...
Five new indications of Lipitor approved by health regulators
The Korea Food and Drug Administration has recently approved new indications of Lipitor (atorvastatin calcium) to reduce the risk of nonfatal heart attacks, fatal and non-fatal strokes, certain types of heart surgery,...
Small pharmaceutical firms to be shaken by new GMP policySmall- and medium-sized companies are worried about financial pinch due to planned implementation of a new current good manufacturing practice (cGMP) system and validation from ...
|
